| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/12/2014 | WO2014138502A1 Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure |
| 09/12/2014 | WO2014138088A1 Bmp inhibitors and methods of use thereof |
| 09/12/2014 | WO2014136910A1 ANTIBODY TO PEPTIDE ENCODED BY Exon-21 OF PERIOSTIN, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF INFLAMMATORY DISEASE CONTAINING SAID ANTIBODY |
| 09/12/2014 | WO2014136808A1 Cell-death inhibitor, and production method therefor |
| 09/12/2014 | WO2014136807A1 Cell-death inhibitor, and novel compound |
| 09/12/2014 | WO2014136681A1 Water-soluble flavonoid composition; drink, food, pharmaceutical product and cosmetic product, each of which contains same; and method for producing water-soluble flavonoid composition |
| 09/12/2014 | WO2014135674A1 Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals |
| 09/12/2014 | WO2014135561A1 New dihydroquinoline-2-one derivatives as aldosterone synthase (cyp1 1 b2 or cyp1 1 b1 ) inhibitors |
| 09/12/2014 | WO2014135280A1 Targeted delivery of nanoparticles to epicardial derived cells (epdc) |
| 09/12/2014 | WO2014134756A1 Topical hemorrhoid medicine |
| 09/11/2014 | US20140255493 Extrudate and methods of using said extrudate |
| 09/10/2014 | EP2774914A1 N-benzylaniline derivative and uses thereof |
| 09/10/2014 | EP2774910A1 Enantiomers of 2-hydroxy derivatives of fatty acids |
| 09/10/2014 | EP2774609A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 09/10/2014 | EP2774606A1 Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV |
| 09/10/2014 | EP2773640A1 Bicyclic piperazine compounds |
| 09/10/2014 | EP2773620A1 Ivabradine hydrochloride form iv |
| 09/10/2014 | EP2773609A2 Nicotinic receptor non-competitive modulators |
| 09/10/2014 | EP2773376A1 Polyethylene glycol based prodrug of adrenomedullin and use thereof |
| 09/10/2014 | EP2773335A1 Neprilysin inhibitors |
| 09/09/2014 | US8829028 5-HT4 receptor antagonists for the treatment of heart failure |
| 09/09/2014 | US8828973 Compounds as receptor modulators with therapeutic utility |
| 09/09/2014 | US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 09/09/2014 | US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/09/2014 | US8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA |
| 09/09/2014 | US8828359 Particulate materials |
| 09/09/2014 | CA2615577C Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 09/09/2014 | CA2600653C Pluripotent stem cell derived from cardiac tissue |
| 09/09/2014 | CA2596755C Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase |
| 09/04/2014 | WO2014134585A1 Inorganic nitrite to improve cardiopulmonary hemodynamics |
| 09/04/2014 | WO2014134419A1 Use of ikach blockers for the treatment of cardiac diseases |
| 09/04/2014 | WO2014134391A1 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors |
| 09/04/2014 | WO2014134388A1 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors |
| 09/04/2014 | US20140249232 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 09/04/2014 | US20140248700 Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells |
| 09/03/2014 | EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof |
| 09/03/2014 | EP2772482A1 Azole derivative |
| 09/03/2014 | EP2772481A1 Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof |
| 09/03/2014 | EP2771345A1 Fused bicyclic oxazolidinone cetp inhibitor |
| 09/03/2014 | EP2771340A1 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 09/03/2014 | EP2771327A1 Novel pyrazine derivatives |
| 09/03/2014 | EP2771025A1 A polypeptide for the protection against heart ischemia-reperfusion injury |
| 09/03/2014 | EP2770992A1 Agents, methods, and devices for affecting nerve function |
| 09/03/2014 | EP2770984A1 Device and method for sustained release of therapeutic agent |
| 09/02/2014 | US8822637 Somatostatin analogues |
| 09/02/2014 | US8822636 Peptides for activation and inhibition of δPKC |
| 09/02/2014 | US8822458 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/02/2014 | US8822453 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation |
| 09/02/2014 | US8822449 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 09/02/2014 | CA2645488C Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions |
| 08/28/2014 | WO2014130947A1 Pyrazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 08/28/2014 | WO2014128693A1 Composition for treating hemorrhoids |
| 08/28/2014 | WO2014128109A1 Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate |
| 08/28/2014 | WO2013126590A8 Pharmaceutical composition comprising cd34+ cells |
| 08/28/2014 | US20140243414 Pharmaceutical compositions of cetp inhibitors |
| 08/28/2014 | US20140242691 Neural Progenitor Cell Populations |
| 08/28/2014 | US20140242166 Sustained release matrix systems for highly soluble drugs |
| 08/28/2014 | US20140242086 Polynucleotides encoding signal peptide-containing molecules |
| 08/27/2014 | EP2769976A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 08/27/2014 | EP2769718A1 Medicinal composition |
| 08/27/2014 | EP2769716A1 Pharmaceutical composition comprising fluoxetine as an active ingredient, for preventing or treating blood-brain barrier disorders |
| 08/27/2014 | EP2768959A2 Compounds for treatment of ischemic injury |
| 08/27/2014 | EP2768832A1 Novel substituted imidazopyrimidines as gpbar1 receptor modulators |
| 08/27/2014 | EP2768812A1 Acid addition salts of bosentan |
| 08/27/2014 | EP2768502A2 Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors |
| 08/27/2014 | EP2768501A1 Method for treating capillary hemangiomas |
| 08/26/2014 | US8815845 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 08/26/2014 | US8815821 Double-stranded oligonucleotides |
| 08/26/2014 | US8815285 Extended release dosage forms of metoprolol |
| 08/26/2014 | US8814926 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 08/26/2014 | CA2407784C Treatment of acute coronary syndrome with glp-1 |
| 08/21/2014 | WO2014127038A1 Methods and compositions related to calcium homeostasis and fabry disease |
| 08/21/2014 | WO2014126979A1 Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors |
| 08/21/2014 | WO2014126972A1 Substituted bisphenyl butanoic acid derivatives as nep inhibitors with improved in vivo efficacy |
| 08/21/2014 | WO2014126582A1 IL-1β INHIBITOR COMPOSITION AND USE THEREOF |
| 08/21/2014 | WO2014125413A1 Ip receptor agonist heterocyclic compounds |
| 08/21/2014 | WO2014125277A1 Method of producing microparticles |
| 08/21/2014 | WO2014125276A1 Stem cell microparticles and mirna |
| 08/21/2014 | WO2014125110A1 Abhd5 and partial hdac4 fragments and variants as therapeutic approach for the treatment of cardiovascular diseases |
| 08/21/2014 | WO2014124803A1 Plant extract of inula racemosa |
| 08/21/2014 | WO2014124487A1 Ligand binding molecules and uses thereof |
| 08/21/2014 | WO2014087231A3 Pharmaceutical composition having a neuroprotective, nootropic, antiamnesic effect, and method for preventing and/or treating states associated with cerebral circulation disorders, cerebrovascular and neurodegenerative diseases |
| 08/21/2014 | US20140234299 Therapies for chronic renal failure using one or more integrin antagonists |
| 08/20/2014 | EP2767537A1 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 08/20/2014 | EP2767533A1 Derivative of butylphthalide and preparation method and use thereof |
| 08/20/2014 | EP2767291A2 Treatment of glycogen storage disease type II |
| 08/20/2014 | EP2766390A1 Compositions and methods for treating heart failure |
| 08/20/2014 | EP2766042A1 ANTIBODIES TO CD1d |
| 08/20/2014 | EP2766022A1 Cannabinoid-2-receptor agonists |
| 08/20/2014 | EP2766017A1 Methods for treating a stroke-related sensorimotor impairment using aminopyridines |
| 08/19/2014 | US8809326 Isoquinolinone Rho kinase inhibitors |
| 08/19/2014 | US8809323 Therapeutic applications of pro-apoptotic benzodiazepines |
| 08/19/2014 | US8809270 Method for reducing cardiovascular morbidity and mortality in prediaetic patients and patients with type 2 diabetes |
| 08/19/2014 | US8809260 β-arrestin effectors and compositions and methods of use thereof |
| 08/19/2014 | US8809011 HIFα hydroxylation assay |
| 08/19/2014 | US8808731 Adhesive pharmaceutical preparation containing bisoprolol |
| 08/19/2014 | US8808691 Method for treating tumors and their metastases |
| 08/19/2014 | US8808669 Gastroretentive, extended release composition of therapeutic agent |
| 08/19/2014 | CA2630704C Pharmaceutical composition |
| 08/19/2014 | CA2623462C Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them |